Microbes Rule

Courtesy of Gordon Vrdoljak, UC, Berkeley  Pseudomonas syringae (left) and Pediococcus pentosaceus (right) Over the past year, major English-language newspapers worldwide have printed six stories about microbial genomes, as compared with 485 stories on the Human Genome Project.1 Yet, scientists have sequenced and published nearly 100 complete microbial genomes. Dozens more have been draft-sequenced, providing unpublished data that have gaps but are still usable. The public and press may

Written byLeslie Pray
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Over the past year, major English-language newspapers worldwide have printed six stories about microbial genomes, as compared with 485 stories on the Human Genome Project.1 Yet, scientists have sequenced and published nearly 100 complete microbial genomes. Dozens more have been draft-sequenced, providing unpublished data that have gaps but are still usable.

The public and press may be too enamored with the Human Genome Project (HGP) to pay much attention to the invisible world of microbes. But scientists, sequencing tools in hand, are finding microorganisms full of remarkable industrial potential. Microbial genomic data are paving the way for new and improved vaccines, better-tasting and safer fermented foods and beverages, stronger biodefense, and a cleaner environment.

"Most people ... don't appreciate that, to put it bluntly, microbes rule. They operate this planet, we don't. I think they should be getting vastly more attention," says Dan Drell, program director of the US Department ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies